<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; Research Reports</title>
	<atom:link href="http://pharmaexecnews.com/category/pharmaceuticals/research-reports/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Novartis Files for Bexsero Approval</title>
		<link>http://pharmaexecnews.com/biotechnology/novartis-files-bexsero-approval/</link>
		<comments>http://pharmaexecnews.com/biotechnology/novartis-files-bexsero-approval/#comments</comments>
		<pubDate>Fri, 31 Dec 2010 08:00:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11022</guid>
		<description><![CDATA[Novartis has submitted its meningococcal B vaccine Bexsero to the EU for marketing approval. &#8220;The Bexsero submission in the EU is an important milestone toward achieving the world&#8217;s first broad-coverage MenB vaccine through our unique multi-component approach,&#8221; said Andrin Oswald, head of Novartis Vaccines and Diagnostics Division. &#8220;Meningococcal disease is sudden and aggressive, leaving little [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/novartis-files-bexsero-approval/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dry Powder Inhaler Stays Strong Even if Breath is Weak</title>
		<link>http://pharmaexecnews.com/biotechnology/dry-powder-inhaler-stays-strong-breath-weak/</link>
		<comments>http://pharmaexecnews.com/biotechnology/dry-powder-inhaler-stays-strong-breath-weak/#comments</comments>
		<pubDate>Tue, 14 Dec 2010 08:00:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10970</guid>
		<description><![CDATA[MedGadget blog tells us about a new dry powder inhaler that, according to Cambridge Consultants and India&#8217;s Sun Pharma Advanced Research Company (SPARC), delivers an even drug dose deep into the lungs no matter how strong the patient&#8217;s inhalation.

The device uses a &#8220;de-agglomeration engine&#8221; to separate the drug from the lactose &#8216;carrier&#8217; particles. The companies [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/dry-powder-inhaler-stays-strong-breath-weak/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Veterans with Bipolar Disorder May Have Increased Risk of Suicide</title>
		<link>http://pharmaexecnews.com/biotechnology/veterans-bipolar-disorder-increased-risk-suicide/</link>
		<comments>http://pharmaexecnews.com/biotechnology/veterans-bipolar-disorder-increased-risk-suicide/#comments</comments>
		<pubDate>Fri, 12 Nov 2010 08:00:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10880</guid>
		<description><![CDATA[Veterans diagnosed with any psychiatric illness appear to have an elevated risk of suicide, and men with bipolar disorder and women with substance abuse disorders may have a particularly high risk, according to the Archives of General Psychiatry.

An estimated 90 percent to 98 percent of individuals who die from suicide meet criteria for at least [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/veterans-bipolar-disorder-increased-risk-suicide/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Amgen Proposes Key Hurdles for Biosimilar Regs</title>
		<link>http://pharmaexecnews.com/biotechnology/amgen-proposes-key-hurdles-biosimilar-regs/</link>
		<comments>http://pharmaexecnews.com/biotechnology/amgen-proposes-key-hurdles-biosimilar-regs/#comments</comments>
		<pubDate>Thu, 11 Nov 2010 08:00:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10876</guid>
		<description><![CDATA[The FDA&#8217;s marathon run toward a new set of regulations to govern the development of biosimilars is official. Regulators will host their first public meeting on follow-on drug regs, and you can expect to hear plenty from big companies like Amgen on the need for lengthy and expensive clinical trials.

As Reuters notes, the agency has [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/amgen-proposes-key-hurdles-biosimilar-regs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Higher Income Parents Forgoing Kids&#8217; Vaccinations</title>
		<link>http://pharmaexecnews.com/biotechnology/higher-income-parents-forgoing-kids-vaccinations/</link>
		<comments>http://pharmaexecnews.com/biotechnology/higher-income-parents-forgoing-kids-vaccinations/#comments</comments>
		<pubDate>Mon, 08 Nov 2010 08:00:02 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10884</guid>
		<description><![CDATA[Vaccination rates for children insured by commercial plans declined roughly four percentage points between 2008 and 2009. And experts fear that if this trend continues, the public&#8217;s health could be jeopardized.  &#8221;Rates had been gradually improving in the commercial plans. This was the first time we&#8217;d seen a drop&#8211;and it was a pretty big drop,&#8221; [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/higher-income-parents-forgoing-kids-vaccinations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diabetes to Double or Triple in U.S. by 2050</title>
		<link>http://pharmaexecnews.com/biotechnology/biomedical/diabetes-double-triple-2050/</link>
		<comments>http://pharmaexecnews.com/biotechnology/biomedical/diabetes-double-triple-2050/#comments</comments>
		<pubDate>Thu, 04 Nov 2010 08:00:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10855</guid>
		<description><![CDATA[Up to a third of U.S. adults could have diabetes by 2050 if Americans continue to gain weight and avoid exercise, said the Centers for Disease Control and Prevention. The numbers are certain to go up as the population gets older, but they will accelerate even more unless Americans change their behavior, the CDC said.

&#8220;We [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/biomedical/diabetes-double-triple-2050/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Parkinson’s Drug Development</title>
		<link>http://pharmaexecnews.com/biotechnology/parkinsons-drug-development/</link>
		<comments>http://pharmaexecnews.com/biotechnology/parkinsons-drug-development/#comments</comments>
		<pubDate>Tue, 02 Nov 2010 08:00:21 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10846</guid>
		<description><![CDATA[The side effects of the standard medication for Parkinson&#8217;s disease have long been a preoccupation of brain researchers. Now Daniella Rylander has presented new findings in a recently defended PhD thesis at Lund University that provide hope of more effective medication for those who suffer from the nerve cell disease.

In her thesis, neuroscience researcher Daniella [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/parkinsons-drug-development/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drug Wholesalers Enjoy a Financial Boost This Year</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/drug-wholesalers-enjoy-financial-boost-year/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/drug-wholesalers-enjoy-financial-boost-year/#comments</comments>
		<pubDate>Fri, 22 Oct 2010 08:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Companies]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Generics]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[generic drugs]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10814</guid>
		<description><![CDATA[The Big 3 drug wholesalers in the U.S.&#8211;AmerisourceBergen, McKesson and Cardinal Health&#8211;are enjoying a financial boost this year thanks to the growing use of generic drugs. That&#8217;s a bus they hope to ride into 2011 and beyond, when they can expect drug distribution&#8217;s next big business-shaker: healthcare reform.

Wholesalers rely on their ability to purchase large [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/drug-wholesalers-enjoy-financial-boost-year/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma Protests Indian Licensing Proposal</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/pharma-protests-indian-licensing-proposal/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/pharma-protests-indian-licensing-proposal/#comments</comments>
		<pubDate>Thu, 14 Oct 2010 08:00:35 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Deals and Mergers]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10791</guid>
		<description><![CDATA[The Indian pharmaceutical industry has been shaken up lately, worried that multinational drugmakers will come in and completely take over their drug market. The fears aren&#8217;t unfounded; Big Pharma, after all, has been targeting the subcontinent as a key location for expansion, as sales-growth slows in the U.S. and Europe.

The country wants foreign investment in [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/pharma-protests-indian-licensing-proposal/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cloaking Device Boldly Delivers Toxins to Tumor</title>
		<link>http://pharmaexecnews.com/biotechnology/bioinformatics/cloaking-device-boldly-delivers-toxins-tumor/</link>
		<comments>http://pharmaexecnews.com/biotechnology/bioinformatics/cloaking-device-boldly-delivers-toxins-tumor/#comments</comments>
		<pubDate>Wed, 13 Oct 2010 08:00:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10787</guid>
		<description><![CDATA[Yes, Star Trek geeks can rejoice. There is now a &#8220;cloaking device&#8221; for drug delivery. At least, that&#8217;s how researchers at the University  of Massachusetts Amherst describe what they&#8217;re doing. In the current issue of Nature Chemistry, Vincent Rotello says he and his team can deliver a dormant toxin into a specific site such [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/bioinformatics/cloaking-device-boldly-delivers-toxins-tumor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

